109 related articles for article (PubMed ID: 23473371)
1. In vitro functional analyses of the human immunodeficiency virus type 1 (HIV-1) integrase mutants give new insights into the intasome assembly.
Cellier C; Moreau K; Gallay K; Ballandras A; Gouet P; Ronfort C
Virology; 2013 May; 439(2):97-104. PubMed ID: 23473371
[TBL] [Abstract][Full Text] [Related]
2. Hyrtiosal, from the marine sponge Hyrtios erectus, inhibits HIV-1 integrase binding to viral DNA by a new inhibitor binding site.
Du L; Shen L; Yu Z; Chen J; Guo Y; Tang Y; Shen X; Jiang H
ChemMedChem; 2008 Jan; 3(1):173-80. PubMed ID: 17943714
[TBL] [Abstract][Full Text] [Related]
3. Selection of amino acid substitutions restoring activity of HIV-1 integrase mutated in its catalytic site using the yeast Saccharomyces cerevisiae.
Parissi V; Caumont AB; de Soultrait VR; Calmels C; Pichuantes S; Litvak S; Dupont CH
J Mol Biol; 2000 Jan; 295(4):755-65. PubMed ID: 10656788
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the functional domains of human foamy virus integrase using chimeric integrases.
Lee HS; Kang SY; Shin CG
Mol Cells; 2005 Apr; 19(2):246-55. PubMed ID: 15879710
[TBL] [Abstract][Full Text] [Related]
5. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.
Esposito D; Craigie R
EMBO J; 1998 Oct; 17(19):5832-43. PubMed ID: 9755183
[TBL] [Abstract][Full Text] [Related]
6. [Interactions of HIV-1 DNA heterocyclic bases with viral DNA].
Agapkina IuIu; Tashlitskiĭ VN; Deprez E; Brochon JC; Shugaliĭ AV; Mouscadet JF; Gottikh MB
Mol Biol (Mosk); 2004; 38(5):848-57. PubMed ID: 15554187
[TBL] [Abstract][Full Text] [Related]
7. HIV-1 integration: an interplay between HIV-1 integrase, cellular and viral proteins.
Van Maele B; Debyser Z
AIDS Rev; 2005; 7(1):26-43. PubMed ID: 15875659
[TBL] [Abstract][Full Text] [Related]
8. Genetic analyses of DNA-binding mutants in the catalytic core domain of human immunodeficiency virus type 1 integrase.
Lu R; Limón A; Ghory HZ; Engelman A
J Virol; 2005 Feb; 79(4):2493-505. PubMed ID: 15681450
[TBL] [Abstract][Full Text] [Related]
9. Genetic analyses of conserved residues in the carboxyl-terminal domain of human immunodeficiency virus type 1 integrase.
Lu R; Ghory HZ; Engelman A
J Virol; 2005 Aug; 79(16):10356-68. PubMed ID: 16051828
[TBL] [Abstract][Full Text] [Related]
10. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
[TBL] [Abstract][Full Text] [Related]
11. GCN5-dependent acetylation of HIV-1 integrase enhances viral integration.
Terreni M; Valentini P; Liverani V; Gutierrez MI; Di Primio C; Di Fenza A; Tozzini V; Allouch A; Albanese A; Giacca M; Cereseto A
Retrovirology; 2010 Mar; 7():18. PubMed ID: 20226045
[TBL] [Abstract][Full Text] [Related]
12. Stimulation of the HIV-1 integrase enzymatic activity and cDNA integration by a peptide derived from the integrase protein.
Levin A; Hayouka Z; Helfer M; Brack-Werner R; Friedler A; Loyter A
Biopolymers; 2010 Aug; 93(8):740-51. PubMed ID: 20517955
[TBL] [Abstract][Full Text] [Related]
13. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus.
Vandekerckhove L; Christ F; Van Maele B; De Rijck J; Gijsbers R; Van den Haute C; Witvrouw M; Debyser Z
J Virol; 2006 Feb; 80(4):1886-96. PubMed ID: 16439544
[TBL] [Abstract][Full Text] [Related]
14. A novel Vpr peptide interactor fused to integrase (IN) restores integration activity to IN-defective HIV-1 virions.
Kulkosky J; BouHamdan M; Geist A; Pomerantz RJ
Virology; 1999 Mar; 255(1):77-85. PubMed ID: 10049823
[TBL] [Abstract][Full Text] [Related]
15. Multiple integrase functions are required to form the native structure of the human immunodeficiency virus type I intasome.
Chen H; Wei SQ; Engelman A
J Biol Chem; 1999 Jun; 274(24):17358-64. PubMed ID: 10358097
[TBL] [Abstract][Full Text] [Related]
16. Changes to the HIV long terminal repeat and to HIV integrase differentially impact HIV integrase assembly, activity, and the binding of strand transfer inhibitors.
Dicker IB; Samanta HK; Li Z; Hong Y; Tian Y; Banville J; Remillard RR; Walker MA; Langley DR; Krystal M
J Biol Chem; 2007 Oct; 282(43):31186-96. PubMed ID: 17715137
[TBL] [Abstract][Full Text] [Related]
17. Contribution of the C-terminal region within the catalytic core domain of HIV-1 integrase to yeast lethality, chromatin binding and viral replication.
Xu Z; Zheng Y; Ao Z; Clement M; Mouland AJ; Kalpana GV; Belhumeur P; Cohen EA; Yao X
Retrovirology; 2008 Nov; 5():102. PubMed ID: 19014595
[TBL] [Abstract][Full Text] [Related]
18. Pre-organized structure of viral DNA at the binding-processing site of HIV-1 integrase.
Renisio JG; Cosquer S; Cherrak I; El Antri S; Mauffret O; Fermandjian S
Nucleic Acids Res; 2005; 33(6):1970-81. PubMed ID: 15814814
[TBL] [Abstract][Full Text] [Related]
19. Target-sequence preferences of HIV-1 integration complexes in vitro.
Bor YC; Miller MD; Bushman FD; Orgel LE
Virology; 1996 Aug; 222(1):283-8. PubMed ID: 8806511
[TBL] [Abstract][Full Text] [Related]
20. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
Robinson WE; Cordeiro M; Abdel-Malek S; Jia Q; Chow SA; Reinecke MG; Mitchell WM
Mol Pharmacol; 1996 Oct; 50(4):846-55. PubMed ID: 8863829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
